
Progress toward a cure for hemophilia: gene editing explained
The World Federation of Hemophilia (WFH) hosted an educational webinar titled “Progress toward a cure for hemophilia: gene editing explained”
Year: 2024
Language: English
Author(s): World Federation of Hemophilia
The WFH Shared Decision Making (SDM) Workbook is for people with hemophilia A or B and their healthcare team. It defines the best practice for shared decision-making in hemophilia treatment and care, and provides a guide for people with hemophilia, caregivers, and healthcare professionals to facilitate successful shared decision-making.
The WFH SDM Tool is a “living” tool that will be updated with new evidence twice per calendar year. The cutoff dates for new data or evidence are June 30 and December 31, with updates taking place in the following month(s). Any new evidence after these cutoffs will be included in the next update.
SDM Tool
The WFH SDM Tool is supported by an educational grant from F. Hoffman-La Roche, Pfizer, Sanofi and Sobi.
The WFH does not engage in the practice of medicine and under no circumstances recommends particular treatment for specific individuals. For diagnosis or consultation on a specific medical problem, the WFH recommends that you contact your physician or local treatment centre. Before administering any products, the WFH urges patients to check dosages with a physician or hemophilia centre staff, and to consult the pharmaceutical company’s printed instructions.
The WFH does not promote any particular pharmaceutical product and any mention of any commercial brand in this presentation is strictly for educational purposes.

The World Federation of Hemophilia (WFH) hosted an educational webinar titled “Progress toward a cure for hemophilia: gene editing explained”

The World Federation of Hemophilia invited representatives from its national member organizations, national governments, healthcare providers, industry partners, and other

A summary of discussions held at the Thirteenth WFH Global Forum on Research and Treatment Products for Bleeding Disorders which

A summary of discussions held at the Twelfth WFH Global Forum on Research and Treatment Products for Bleeding Disorders which

This video gives a quick introduction to ultra-long half-life (UHL) clotting factor replacement therapy. Learn more about different treatment options

The 3rd edition of the WFH laboratory Manual is the definitive how-to guide for the accurate diagnosis of hemophilia and